The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

PHEA     2-phenylethanamine

Synonyms: Phenethylamine, CHEMBL610, SureCN968, PubChem21080, AGN-PC-00EOQ1, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Phenethylammonium chloride


Psychiatry related information on Phenethylammonium chloride


High impact information on Phenethylammonium chloride


Chemical compound and disease context of Phenethylammonium chloride


Biological context of Phenethylammonium chloride


Anatomical context of Phenethylammonium chloride


Associations of Phenethylammonium chloride with other chemical compounds


Gene context of Phenethylammonium chloride


Analytical, diagnostic and therapeutic context of Phenethylammonium chloride


  1. Letter: Chocolate, beta-phenethylamine and migraine re-examined. Schweitzer, J.W., Friedhoff, A.J., Schwartz, R. Nature (1975) [Pubmed]
  2. Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy. Mizock, B.A., Sabelli, H.C., Dubin, A., Javaid, J.I., Poulos, A., Rackow, E.C. Arch. Intern. Med. (1990) [Pubmed]
  3. Temporal association between depression-dependent dyskinesias and high urinary phenylethylamine output. Linnoila, M., Karoum, F., Cutler, N.R., Potter, W.Z. Biol. Psychiatry (1983) [Pubmed]
  4. Switching between allosteric and dimerization inhibition of HIV-1 protease. Bowman, M.J., Byrne, S., Chmielewski, J. Chem. Biol. (2005) [Pubmed]
  5. Decreased cerebrospinal fluid levels of beta-phenylethylamine in patients with Rett syndrome. Satoi, M., Matsuishi, T., Yamada, S., Yamashita, Y., Ohtaki, E., Mori, K., Riikonen, R., Kato, H., Percy, A.K. Ann. Neurol. (2000) [Pubmed]
  6. Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder. Zametkin, A.J., Brown, G.L., Karoum, F., Rapoport, J.L., Langer, D.H., Chuang, L.W., Wyatt, R.J. The American journal of psychiatry. (1984) [Pubmed]
  7. Dose-response effects of beta-phenylethylamine on stereotyped behavior in pargyline-pretreated rats. Moja, E.A., Stoff, D.M., Gillin, J.C., Wyatt, R.J. Biol. Psychiatry (1976) [Pubmed]
  8. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. Sterling, J., Herzig, Y., Goren, T., Finkelstein, N., Lerner, D., Goldenberg, W., Miskolczi, I., Molnar, S., Rantal, F., Tamas, T., Toth, G., Zagyva, A., Zekany, A., Finberg, J., Lavian, G., Gross, A., Friedman, R., Razin, M., Huang, W., Krais, B., Chorev, M., Youdim, M.B., Weinstock, M. J. Med. Chem. (2002) [Pubmed]
  9. Increased stress response and beta-phenylethylamine in MAOB-deficient mice. Grimsby, J., Toth, M., Chen, K., Kumazawa, T., Klaidman, L., Adams, J.D., Karoum, F., Gal, J., Shih, J.C. Nat. Genet. (1997) [Pubmed]
  10. (+)-Amphetamine binding to rat hypothalamus: relation to anorexic potency for phenylethylamines. Paul, S.M., Hulihan-Giblin, B., Skolnick, P. Science (1982) [Pubmed]
  11. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD. Kusaga, A., Yamashita, Y., Koeda, T., Hiratani, M., Kaneko, M., Yamada, S., Matsuishi, T. Ann. Neurol. (2002) [Pubmed]
  12. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Aghajanian, G.K., Marek, G.J. Brain Res. Brain Res. Rev. (2000) [Pubmed]
  13. Evidence for the presence of m-tyramine, p-tyramine, tryptamine, and phenylethylamine in the rat brain and several areas of the human brain. Philips, S.R., Rozdilsky, B., Boulton, A.A. Biol. Psychiatry (1978) [Pubmed]
  14. Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats. Freemark, M., Stoff, D.M., Moja, E.A., Gillin, J.C., Wyatt, R.J. Biol. Psychiatry (1978) [Pubmed]
  15. A review of the physiological bases of the anorexic action of phenylpropanolamine (d,1-norephedrine). Wellman, P.J. Neuroscience and biobehavioral reviews. (1990) [Pubmed]
  16. An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies. Mohammad, R.M., Al-Katib, A., Pettit, G.R., Vaitkevicius, V.K., Joshi, U., Adsay, V., Majumdar, A.P., Sarkar, F.H. Clin. Cancer Res. (1998) [Pubmed]
  17. Monoamine oxidase in rat and bovine endocrine tissues. Lenzen, S., Freisinger-Treichel, M., Panten, U. J. Neurochem. (1987) [Pubmed]
  18. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. Lenders, J.W., Eisenhofer, G., Abeling, N.G., Berger, W., Murphy, D.L., Konings, C.H., Wagemakers, L.M., Kopin, I.J., Karoum, F., van Gennip, A.H., Brunner, H.G. J. Clin. Invest. (1996) [Pubmed]
  19. Catabolism of phenylacetic acid in Escherichia coli. Characterization of a new aerobic hybrid pathway. Ferrández, A., Miñambres, B., García, B., Olivera, E.R., Luengo, J.M., García, J.L., Díaz, E. J. Biol. Chem. (1998) [Pubmed]
  20. Copper/topa quinone-containing histamine oxidase from Arthrobacter globiformis. Molecular cloning and sequencing, overproduction of precursor enzyme, and generation of topa quinone cofactor. Choi, Y.H., Matsuzaki, R., Fukui, T., Shimizu, E., Yorifuji, T., Sato, H., Ozaki, Y., Tanizawa, K. J. Biol. Chem. (1995) [Pubmed]
  21. Structure-activity relationships of phenethylamine. a comparison of quantum mechanical SCF "Ab initio" and semiempirical calculations. Martín, M., Carbó, R., Petrongolo, C., Tomasi, J. J. Am. Chem. Soc. (1975) [Pubmed]
  22. Phenylethylamine and cerebral blood flow. Possible involvement of phenylethylamine in migraine. McCulloch, J., Harper, A.M. Neurology (1977) [Pubmed]
  23. Monoamine oxidase, an intracellular probe of oxygen pressure in isolated cardiac myocytes. Katz, I.R., Wittenberg, J.B., Wittenberg, B.A. J. Biol. Chem. (1984) [Pubmed]
  24. A new animal model for schizophrenia: interactions with adrenergic mechanisms. Borison, R.L., Diamond, B.I. Biol. Psychiatry (1978) [Pubmed]
  25. 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system? Paterson, I.A., Juorio, A.V., Boulton, A.A. J. Neurochem. (1990) [Pubmed]
  26. Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity. Rasmussen, K., Aghajanian, G.K. Neuropsychopharmacology (1988) [Pubmed]
  27. Xenobiotic enzyme profiles and Parkinson's disease. Williams, A., Steventon, G., Sturman, S., Waring, R. Neurology (1991) [Pubmed]
  28. Improved method for HPLC analysis of polyamines, agmatine and aromatic monoamines in plant tissue. Slocum, R.D., Flores, H.E., Galston, A.W., Weinstein, L.H. Plant Physiol. (1989) [Pubmed]
  29. Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase. Grunewald, G.L., Ye, Q., Sall, D.J., Criscione, K.R., Wise, B. Mol. Pharmacol. (1989) [Pubmed]
  30. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys. Staub, R.A., Gillin, J.C., Wyatt, R.J. Biol. Psychiatry (1980) [Pubmed]
  31. Monoamine oxidase: from genes to behavior. Shih, J.C., Chen, K., Ridd, M.J. Annu. Rev. Neurosci. (1999) [Pubmed]
  32. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. Kurrasch-Orbaugh, D.M., Watts, V.J., Barker, E.L., Nichols, D.E. J. Pharmacol. Exp. Ther. (2003) [Pubmed]
  33. 2-phenylethylamine catabolism by Escherichia coli K-12: gene organization and expression. Hanlon, S.P., Hill, T.K., Flavell, M.A., Stringfellow, J.M., Cooper, R.A. Microbiology (Reading, Engl.) (1997) [Pubmed]
  34. Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex. Guimarães, J.T., Vindis, C., Soares-da-Silva, P., Parini, A. Life Sci. (2003) [Pubmed]
  35. Effects of tibalosine, a new alpha-adrenoceptor antagonist, in essential hypertension. Staessen, J., Fagard, R., Grauwels, R., Lijnen, P., Verschueren, L.J., Amery, A. Clin. Pharmacol. Ther. (1983) [Pubmed]
  36. Phenethylamine in normal urine: failure to verify high values. Schweitzer, J.W., Friedhoff, A.J., Schwartz, R. Biol. Psychiatry (1975) [Pubmed]
  37. Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain. Constantine, K.L., Madrid, M., Bányai, L., Trexler, M., Patthy, L., Llinás, M. J. Mol. Biol. (1992) [Pubmed]
  38. Identification and distribution of phenylacetic acid in the brain of the rat. Durden, D.A., Boulton, A.A. J. Neurochem. (1982) [Pubmed]
  39. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum. Juorio, A.V., Paterson, I.A., Zhu, M.Y., Matte, G. J. Neurochem. (1991) [Pubmed]
WikiGenes - Universities